Gaucher’s disease gene therapy (Ibex)

N/A

Report date: 2025/03/20 15:39:31

Base Information

Drug NameGaucher’s disease gene therapy (Ibex)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBeta-glucocerebrosidase modulators
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIbex Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesIbex Biosciences LLC
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A